MGTX — MeiraGTx Holdings plc

—
Nasdaq · Health Care · Biotechnology · CIK 1735438 ·
Last close
$10.91
Market Cap
$1.05B
52W High
$15.35
52W Low
$6.62
ADV30
885,933
Next earnings
2026-11-12

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 321,434,000 314,270,000 244,425,000 160,720,000 396,449,000 143,166,000 180,668,000
Mar 2026 293,000 95,000 -40,817,000 -46,313,000 244,655,000 71,541,000 302,785,000
Dec 2025 75,364,000 74,888,000 26,472,000 15,088,000 244,430,000 65,931,000 250,223,000
Sep 2025 410,000 97,000 -46,051,000 -50,513,000 189,471,000 14,841,000 230,028,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$8,343,000
Investing CF
$-4,655,000
Financing CF
$446,000
CapEx
$-4,784,000
Dividends Paid
—
Buybacks
$-18,193,000
EPS Diluted TTM
$-2.18
As of
2026-08-16

Balance + Analyst (yfinance extras)

Retained Earnings
$-862,536,000
Inventory
$0
Receivables
$17,959,000
ST Investments
—
EBIT TTM
$-108,531,000
Pretax Income TTM
$-120,533,000
Interest Exp TTM
$12,002,000
Analysts
7

Yahoo Snapshot (yfinance, live)

Total Revenue
$397,500,992
EBITDA
$196,131,008
Free Cash Flow
$56,421,000
Enterprise Value
$1,197,753,856
Total Cash
$143,166,000
Total Debt
$112,321,000
Shares Out
96,042,996
Trailing EPS
$0.87
Book Value
$2.29
ROE
72.2%
ROA
38.7%
Div Yield
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 81,391,000 -105,968,000 -114,201,000 244,430,000 250,223,000 -5,793,000 -46,359,000
Dec 2024 33,279,000 -164,212,000 -147,791,000 269,751,000 201,924,000 67,827,000 -104,495,000
Dec 2023 14,017,000 -137,061,000 -84,027,000 326,744,000 188,567,000 138,177,000 -105,365,000
Dec 2022 15,920,000 -116,355,000 -129,615,000 318,237,000 200,499,000 117,738,000 -73,098,000

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-1.39

Max Pain — expiry 2026-10-16

max pain strike: $10.00 · spot: $11.11 · call oi: 1,009 · put oi: 63
Expected Move to 2026-10-16: ±$1.54 (13.81%) — implied range $9.58 – $12.65 · ATM straddle on $10.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
GLUE Monte Rosa Therapeutics, Inc. $1.00B $11.77 —
VOR Vor Biopharma Inc. $1.10B $18.52 —
ODTX Odyssey Therapeutics, Inc. $985.68M $20.51 —
REPL Replimune Group, Inc. $1.16B $12.36 —
CGEM Cullinan Therapeutics, Inc. $910.19M $14.81 —

News headlines (Yahoo Finance, 1h cache)

MeiraGTx Appoints Accomplished Healthcare Portfolio Manager Alan M. Sebulsky to Board of Directors
2026-09-23 12:00 · Yahoo
What Could MeiraGTx Holdings (MGTX) New Hires And Profit Swing Signal?
2026-08-14 23:12 · Yahoo
MeiraGTx Seen Nearing First Commercial Launches as Key Programs Advance, RBC Says
2026-08-14 16:02 · Yahoo
MeiraGTx Holdings PLC (MGTX) Q2 Earnings and Revenues Surpass Estimates
2026-08-13 13:25 · Yahoo
MeiraGTx Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2026-08-06 20:30 · Yahoo
Wall Street Analysts See a 128.14% Upside in MeiraGTx (MGTX): Can the Stock Really Move This High?
2026-07-15 13:55 · Yahoo
What This MeiraGTx Insider Sale Might Mean With Two Drug Filings Near
2026-07-12 19:39 · Yahoo
MeiraGTx Announces $400 million Strategic Investment by Oberland Capital to Support Development and Commercialization of AAV2-hAQP1 and Botaretigene Sparoparvovec (bota-vec)
2026-07-07 11:30 · Yahoo
Can MeiraGTx Holdings PLC (MGTX) Stock Double? Cash Runway Offers a Hint
2026-05-20 12:36 · Yahoo
Here's What Analysts Are Forecasting For MeiraGTx Holdings plc (NASDAQ:MGTX) After Its First-Quarter Results
2026-05-17 13:55 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.